|
Press Releases
All Releases
 |
EnteroMedics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Sep 2, 2008
|
12.6 KB |
|
| |
ST. PAUL, Minn., Sep 02, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Greg S. Lea, Chief Financial Officer, is scheduled to present at the Morgan Stanley Global Healthcare Unplugged Conference in New York, NY on Tuesday, September 9th at4:30 pm ET. Mr. Lea will provide an overview of the Company and an update on its...
|
|
EnteroMedics to Present at the 28th Annual Canaccord Adams Global Growth Conference
Jul 28, 2008
|
12.6 KB |
|
| |
ST. PAUL, Minn., Jul 28, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., Chief Executive Officer, is scheduled to present at the 28th Annual Canaccord Adams Global Growth Conference in Boston, MA on Tuesday, August 12th at 11:30 am ET. Dr. Knudson will provide an overview of the Company and an u...
|
|
EnteroMedics Reports Second Quarter 2008 Financial Results
Jul 24, 2008
|
15.6 KB |
|
| |
ST. PAUL, Minn., Jul 24, 2008 (BUSINESS WIRE) -- EnteroMedics Inc., (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced financial results for the three and six months ended June 30, 2008.
For the three months ended June 30, 2008, the Company repor...
|
|
EnteroMedics Receives ISO 13485:2003 Certification for the Maestro(TM) System
Jun 27, 2008
|
12.3 KB |
|
| |
ST. PAUL, Minn., Jun 27, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it has received ISO 13485:2003 certification from KEMA Quality B.V. for the design, manufacture and distribution of surgical im...
|
|
EnteroMedics to Present at Collins Stewart Fourth Annual Growth Conference
Jun 26, 2008
|
12.2 KB |
|
| |
ST. PAUL, Minn., Jun 26, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., President and Chief Executive Officer, is scheduled to present at the Collins Stewart Fourth Annual Growth Conference in New York, New York on Wednesday, July 9, 2008 at 2:00 PM ET. The presentation will be webcast live and...
|
|
EnteroMedics' Data from VBLOC-RF2 Feasibility Study and VBLOC-RC Study Presented Today at the American Society for Metabolic and Bariatric Surgery Meeting
Jun 19, 2008
|
14.7 KB |
|
| |
WASHINGTON, Jun 19, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced that interim clinical results for the company's VBLOC(TM) vagal blocking therapy device, the Maestro(TM) RF2 System, were presented today at th...
|
|
EnteroMedics to Host Conference Call after Presentation at the 25th Annual American Society for Metabolic and Bariatric Surgery Meeting; Company to present study data and update EMPOWER trial enrollment
Jun 11, 2008
|
13.1 KB |
|
| |
ST. PAUL, Minn., Jun 11, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it expects study results from ongoing clinical trials of the company's VBLOC(TM) vagal blocking therapy to be presented at 3:00...
|
|
EnteroMedics Reports First Quarter 2008 Financial Results
Apr 23, 2008
|
13.6 KB |
|
| |
ST. PAUL, Minn., Apr 23, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today its financial results for the first quarter ended March 31, 2008.
The Company reported a net loss of $8.5 million, or $0.51 per ...
|
|
EnteroMedics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
Apr 22, 2008
|
11.1 KB |
|
| |
ST. PAUL, Minn., Apr 22, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference in Key Biscayne, Florida on Wednesday, April 30, 2008, at 1:40 PM EDT.
The presentation wi...
|
|
EnteroMedics Announces Departure of Russell Felkey
Apr 21, 2008
|
10.9 KB |
|
| |
ST. PAUL, Minn., Apr 21, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that effective April 18, 2008, Russ Felkey, Senior Vice President of Clinical, Quality and Regulatory Affairs has resigned from the Company to pursue other interests. Mr. Felkey's departure is unrelated to the operations or performance of the Company. ...
|
|
EnteroMedics to Present at the 28th Annual Cowen and Company Healthcare Conference
Mar 11, 2008
|
11.2 KB |
|
| |
ST. PAUL, Minn., Mar 11, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., Chief Executive Officer, is scheduled to present at the 28th Annual Cowen and Company Healthcare Conference in Boston, MA on Tuesday, March 18, 2008, at 3:10 PM ET. Dr. Knudson will provide an overview of the Company and an...
|
|
EnteroMedics Announces Planned Expansion of EMPOWER Pivotal Study for Obesity to 300 Patients
Feb 26, 2008
|
13.2 KB |
|
| |
ST. PAUL, Minn., Feb 26, 2008 (BUSINESS WIRE) -- EnteroMedics Inc., (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced that the Food and Drug Administration (FDA) has granted approval for the expansion of its pivotal clinical trial, known as the EMPOW...
|
|
EnteroMedics Reports 2007 Year-End Financial Results
Feb 20, 2008
|
15.1 KB |
|
| |
ST. PAUL, Minn., Feb 20, 2008 (BUSINESS WIRE) -- EnteroMedics Inc., (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced financial results for the year ended December 31, 2007.
For the full year 2007, the company reported a net loss of $28.6 million...
|
|
EnteroMedics Sets Date and Time for 2007 Year-End Update Conference Call
Feb 7, 2008
|
10.3 KB |
|
| |
ST. PAUL, Minn., Feb 07, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM), a development-stage medical device company, plans to release year-end 2007 financial results after market close on Wednesday, February 20, 2008. Mark B. Knudson, Ph.D., chief executive officer, and Greg S. Lea, chief financial officer will discuss the company's finan...
|
|
EnteroMedics(TM) Announces Nine-Month Clinical Results on Its VBLOC-RF2 Feasibility Study for Obesity Therapy
Jan 8, 2008
|
13.2 KB |
|
| |
ST. PAUL, Minn., Jan 08, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ:ETRM), a developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced interim clinical results for the company's Maestro(TM) RF2 System. The Maestro RF2 System is currently being evaluated in 33 obese pati...
|
|
EnteroMedics(TM) Announces Pivotal Clinical Study of its VBLOC(TM) Therapy for Obesity
Jan 7, 2008
|
14.1 KB |
|
| |
ST. PAUL, Minn., Jan 07, 2008 (BUSINESS WIRE) -- EnteroMedics, Inc. (NASDAQ:ETRM), a developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced its EMPOWER pivotal clinical study. The FDA has recently granted approval for the pivotal clinical study of the company's investigatio...
|
|
EnteroMedics to Present at the 26th Annual JPMorgan Healthcare Conference on January 8
Jan 2, 2008
|
11.3 KB |
|
| |
ST. PAUL, Minn., Jan 02, 2008 (BUSINESS WIRE) -- EnteroMedics Inc. (NASDAQ: ETRM) announced today that Mark B. Knudson, Ph.D., chief executive officer, will present at the 26th Annual JPMorgan Healthcare Conference in San Francisco on Tuesday, January 8, 2008, from 4:30-5:00 p.m. PT (6:30 p.m. CT). Dr. Knudson will provide an overview of the compan...
|
|
ENTEROMEDICS ANNOUNCES INITIAL PUBLIC OFFERING
Nov 14, 2007
|
4.6 KB |
|
| |
ST. PAUL, Minn., November 14, 2007 - EnteroMedics Inc. today announced the initial public offering of 5,000,000 shares of common stock at a price of $8 per share. EnteroMedics' common stock is expected to begin trading on the NASDAQ Global Market under the trading symbol ETRM on Thursday, November 15, 2007. All shares of the...
|
|
ENTEROMEDICS FILES REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
May 25, 2007
|
4.3 KB |
|
| |
ST. PAUL, Minn., May 25, 2007 – EnteroMedics Inc. today announced it has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. All shares of the common stock to be sold in this offering will be offered by EnteroMedics.
J.P. Morgan Secur...
|
|
ENTEROMEDICS CLOSES $45.2 MILLION SERIES C FINANCING
Jul 19, 2006
|
5.8 KB |
|
| |
ST. PAUL, Minn., July 19, 2006 – EnteroMedics Inc., a developer of medical devices for the treatment of obesity and gastrointestinal disorders, today announced the closing of a $45.2 million Series C financing round. The company’s VBLOC (Vagal BLocking for Obesity Control) Therapy is currently under clinical investigation for its potential t...
|
|
|
= add release to Briefcase
| | |
| | |
EnteroMedics - 2800 Patton Road - St. Paul,
MN 55113
CAUTION: Investigational device. Limited by Federal law to
investigational use.
This page revised November 2007.
©Copyright 2007 EnteroMedics. All rights
reserved. Nothing in this site, including descriptions of treatments
may be reproduced without written authorization from EnteroMedics.
|
